252 related articles for article (PubMed ID: 35526333)
1. Chromosomal instability as a source of genomic plasticity.
Al-Rawi DH; Bakhoum SF
Curr Opin Genet Dev; 2022 Jun; 74():101913. PubMed ID: 35526333
[TBL] [Abstract][Full Text] [Related]
2. Breaking the vicious circle: Extrachromosomal circular DNA as an emerging player in tumour evolution.
Robert M; Crasta K
Semin Cell Dev Biol; 2022 Mar; 123():140-150. PubMed ID: 34857471
[TBL] [Abstract][Full Text] [Related]
3. Extrachromosomal DNA in Cancer.
Bafna V; Mischel PS
Annu Rev Genomics Hum Genet; 2022 Aug; 23():29-52. PubMed ID: 35609926
[TBL] [Abstract][Full Text] [Related]
4. Chromothripsis drives the evolution of gene amplification in cancer.
Shoshani O; Brunner SF; Yaeger R; Ly P; Nechemia-Arbely Y; Kim DH; Fang R; Castillon GA; Yu M; Li JSZ; Sun Y; Ellisman MH; Ren B; Campbell PJ; Cleveland DW
Nature; 2021 Mar; 591(7848):137-141. PubMed ID: 33361815
[TBL] [Abstract][Full Text] [Related]
5. Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.
Wu S; Bafna V; Chang HY; Mischel PS
Annu Rev Pathol; 2022 Jan; 17():367-386. PubMed ID: 34752712
[TBL] [Abstract][Full Text] [Related]
6. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.
van Leen E; Brückner L; Henssen AG
Nat Genet; 2022 Feb; 54(2):107-114. PubMed ID: 35145302
[TBL] [Abstract][Full Text] [Related]
7. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
Kim H; Nguyen NP; Turner K; Wu S; Gujar AD; Luebeck J; Liu J; Deshpande V; Rajkumar U; Namburi S; Amin SB; Yi E; Menghi F; Schulte JH; Henssen AG; Chang HY; Beck CR; Mischel PS; Bafna V; Verhaak RGW
Nat Genet; 2020 Sep; 52(9):891-897. PubMed ID: 32807987
[TBL] [Abstract][Full Text] [Related]
8. Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution.
Xing J; Ning Q; Tang D; Mo Z; Lei X; Tang S
Clin Genet; 2021 Apr; 99(4):503-512. PubMed ID: 33314031
[TBL] [Abstract][Full Text] [Related]
9. Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.
Piemonte KM; Anstine LJ; Keri RA
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34606589
[TBL] [Abstract][Full Text] [Related]
10. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.
Pecorino LT; Verhaak RGW; Henssen A; Mischel PS
Biochem Soc Trans; 2022 Dec; 50(6):1911-1920. PubMed ID: 36355400
[TBL] [Abstract][Full Text] [Related]
11. [Amplification of Extrachromosomal Oncogene and Tumorigenesis and Development].
Wang Y; Ye F; Zhang X; Zou R; Wang M; Yu K; Cui S
Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1101-1107. PubMed ID: 33357318
[TBL] [Abstract][Full Text] [Related]
12. Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.
Del Rey J; Prat E; Ponsa I; Lloreta J; Gelabert A; Algaba F; Camps J; Miró R
BMC Cancer; 2010 Jun; 10():280. PubMed ID: 20540739
[TBL] [Abstract][Full Text] [Related]
13. Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials.
Salmaninejad A; Ilkhani K; Marzban H; Navashenaq JG; Rahimirad S; Radnia F; Yousefi M; Bahmanpour Z; Azhdari S; Sahebkar A
Curr Pharm Des; 2021; 27(28):3161-3169. PubMed ID: 33902409
[TBL] [Abstract][Full Text] [Related]
14. Targeting the CINful genome: Strategies to overcome tumor heterogeneity.
Cunningham CE; MacAuley MJ; Yadav G; Vizeacoumar FS; Freywald A; Vizeacoumar FJ
Prog Biophys Mol Biol; 2019 Oct; 147():77-91. PubMed ID: 30817936
[TBL] [Abstract][Full Text] [Related]
15. The formation mechanism and homeostasis of extrachromosomal DNA.
Tao Y; Ning Q; Wang Z; Tang N; Zhao X; Tang S
Carcinogenesis; 2022 Oct; 43(9):815-825. PubMed ID: 36037043
[TBL] [Abstract][Full Text] [Related]
16. Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression.
Liao Z; Jiang W; Ye L; Li T; Yu X; Liu L
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188392. PubMed ID: 32735964
[TBL] [Abstract][Full Text] [Related]
17. Extrachromosomal DNA (ecDNA) in cancer pathogenesis.
Wu S; Bafna V; Mischel PS
Curr Opin Genet Dev; 2021 Feb; 66():78-82. PubMed ID: 33477016
[TBL] [Abstract][Full Text] [Related]
18. The evolutionary dynamics of extrachromosomal DNA in human cancers.
Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
[TBL] [Abstract][Full Text] [Related]
19. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
[TBL] [Abstract][Full Text] [Related]
20. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.
Turner KM; Deshpande V; Beyter D; Koga T; Rusert J; Lee C; Li B; Arden K; Ren B; Nathanson DA; Kornblum HI; Taylor MD; Kaushal S; Cavenee WK; Wechsler-Reya R; Furnari FB; Vandenberg SR; Rao PN; Wahl GM; Bafna V; Mischel PS
Nature; 2017 Mar; 543(7643):122-125. PubMed ID: 28178237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
